Oncopeptides AB (LTS:0RN4) 3-Year Book Growth Rate : -58.00% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Oncopeptides AB 3-Year Book Growth Rate?

Oncopeptides AB's Book Value per Share for the quarter that ended in Mar. 2024 was kr-0.07.

During the past 12 months, Oncopeptides AB's average Book Value per Share Growth Rate was -103.70% per year. During the past 3 years, the average Book Value per Share Growth Rate was -58.00% per year. During the past 5 years, the average Book Value per Share Growth Rate was -38.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 10 years, the highest 3-Year average Book Value per Share Growth Rate of Oncopeptides AB was 276.70% per year. The lowest was -58.00% per year. And the median was -14.65% per year.

Competitive Comparison of Oncopeptides AB's 3-Year Book Growth Rate

For the Biotechnology subindustry, Oncopeptides AB's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oncopeptides AB's 3-Year Book Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oncopeptides AB's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Oncopeptides AB's 3-Year Book Growth Rate falls into.

Oncopeptides AB 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

Oncopeptides AB (LTS:0RN4) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

Oncopeptides AB 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Oncopeptides AB's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncopeptides AB (LTS:0RN4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncopeptides AB (LTS:0RN4) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

ONCO:Sweden OND:Germany

Address

Vastra Tradgardsgatan 15, Stockholm, SWE, SE-111 53

Website

https://www.oncopeptides.com

Oncopeptides AB is a biotech company focused on the research, development, and commercialization of therapies for difficult-to-treat hematological diseases. The company uses its proprietary Peptide Drug Candidate platform (PDC) to develop compounds that rapidly and selectively deliver cytotoxic agents into cancer cells. It has focused on the development of the product candidate melflufen (Ygalo), a peptide-conjugated alkylator, belonging to a new class of drugs called Peptidase Enhanced Compounds. Melflufen is intended as an effective treatment for hematological cancers and in particular multiple myeloma.

Oncopeptides AB (LTS:0RN4) Headlines

No Headlines